Motamedi H, Cai S J, Shafiee A, Elliston K O
Dept. of Natural Products Drug Discovery, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Eur J Biochem. 1997 Feb 15;244(1):74-80. doi: 10.1111/j.1432-1033.1997.00074.x.
The immunosuppressant FK506 is a 23-membered macrocyclic polyketide produced by several Streptomyces species. Sequencing of a 19.5-kb contiguous segment of DNA from the FK506 gene cluster of Streptomyces sp. MA6548 revealed the presence of a single 19.3-kb open reading frame designated fkbA. fkbA encodes a component of the FK506 polyketide synthase, a complex enzyme system which catalyzes synthesis of the polyketide portion of FK506. The predicted product of gene fkbA is a 630,660-Da protein (6420 amino acids) that contains 19 independent domains with a high degree of amino acid sequence similarity to the catalytic activities of known fatty acid synthases. The identified domains are arranged into four repeated modules with a linear organization precisely as that of animal fatty acid synthase and type I polyketide synthase. Each module participates in one round of chain extension and subsequent processing and thus FkbA polypeptide catalyzes four of the ten condensation steps required for synthesis of the FK506 macrolactone ring. Disruption of fkbA results in the generation of an FK506 non-producing mutant demonstrating direct involvement of fkbA in the biosynthesis of FK506.
免疫抑制剂FK506是由几种链霉菌属物种产生的一种23元大环聚酮化合物。对链霉菌属MA6548的FK506基因簇中一段19.5 kb的连续DNA片段进行测序,发现存在一个单一的19.3 kb开放阅读框,命名为fkbA。fkbA编码FK506聚酮合酶的一个组分,这是一种复合酶系统,催化FK506聚酮部分的合成。基因fkbA的预测产物是一种630,660 Da的蛋白质(6420个氨基酸),它包含19个独立结构域,与已知脂肪酸合酶的催化活性具有高度的氨基酸序列相似性。所鉴定的结构域排列成四个重复模块,其线性组织与动物脂肪酸合酶和I型聚酮合酶的完全相同。每个模块参与一轮链延伸及后续加工,因此FkbA多肽催化FK506大环内酯环合成所需的十个缩合步骤中的四个。fkbA的破坏导致产生一个不产生FK506的突变体,证明fkbA直接参与FK506的生物合成。